New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing JS Ross, K Wang, L Gay, R Al-Rohil, JV Rand, DM Jones, HJ Lee, ... The oncologist 19 (3), 235-242, 2014 | 532 | 2014 |
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications CR Churi, R Shroff, Y Wang, A Rashid, HSC Kang, J Weatherly, M Zuo, ... PloS one 9 (12), e115383, 2014 | 489 | 2014 |
HER2/neu-directed therapy for biliary tract cancer M Javle, C Churi, HSC Kang, R Shroff, F Janku, R Surapaneni, M Zuo, ... Journal of hematology & oncology 8, 1-9, 2015 | 248 | 2015 |
Overexpression of the HER2/neu gene: a new therapeutic possibility for patients with advanced gallbladder cancer I Roa, G de Toro, K Schalper, X de Aretxabala, C Churi, M Javle Gastrointestinal cancer research: GCR 7 (2), 42, 2014 | 132 | 2014 |
Molecular characterization of gallbladder cancer using somatic mutation profiling M Javle, A Rashid, C Churi, S Kar, M Zuo, AK Eterovic, ... Human pathology 45 (4), 701-708, 2014 | 97 | 2014 |
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer M Zuo, A Rashid, C Churi, JN Vauthey, P Chang, Y Li, MC Hung, D Li, ... British journal of cancer 112 (6), 1042-1051, 2015 | 51 | 2015 |
A web-based tool for patient triage in emergency department settings: validation using the emergency severity index P Elias, A Damle, M Casale, K Branson, N Peterson, C Churi, ... JMIR Medical Informatics 3 (2), e3508, 2015 | 14 | 2015 |
Sexual behaviour among truck drivers halting at Kalamboli Truck Terminal, Navi Mumbai C Churi, S Anjenaya Australasian Medical Journal (Online), 271, 2010 | 6 | 2010 |
Comprehensive genomic profiling of gallbladder adenocarcinoma and frequent genomic-derived targets of therapy. P Stephens, K Wang, NA Palma, J Chmielecki, RT Shroff, C Churi, ... Journal of Clinical Oncology 32 (15_suppl), 4142-4142, 2014 | 3 | 2014 |
Results of an HIV stigma reduction intervention on a university campus SA Millimet, B Miller, MW Ross, P Samson, C Churi International Journal of Child and Adolescent Health 6 (3), 297, 2013 | 3 | 2013 |
BAP1 mutation-associated cholangiocarcinoma: An aggressive disease. D Anand, C Churi, A Rashid, RT Shroff, M Zuo, C Conrad, JN Vauthey, ... Journal of Clinical Oncology 33 (3_suppl), 420-420, 2015 | 2 | 2015 |
Evaluation of an HIV anti-stigma campaign SA Millimet, B Miller, MW Ross, P Samson, C Churi Child and Adolescent Health Issues (A Tribute to the Pediatrician Donald E …, 2015 | 1 | 2015 |
Comparison of microRNA (MiRNA) expression profiles between opisthorchis viverrini-associated cholangiocarcinoma (OV-CCA) and non-opisthorchis viverrini-associated … S Tanasanvimon, A Rashid, S Wongkham, C Churi, Z Tong, ... Journal of Clinical Oncology 31 (4_suppl), 206-206, 2013 | 1 | 2013 |
Metadata Correction: A Web-Based Tool for Patient Triage in Emergency Department Settings: Validation Using the Emergency Severity Index P Elias, A Damle, M Cassale, K Branson, N Peterson, C Churi, ... JMIR Medical Informatics 3 (3), e4816, 2015 | | 2015 |
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA). RT Shroff, C Churi, A Rashid, L Mishra, M Zuo, AO Kaseb, F Janku, ... Journal of Clinical Oncology 32 (3_suppl), 209-209, 2014 | | 2014 |
Abstract C171: Novel therapeutic strategies targeting the hedgehog signaling pathway and mTOR pathway in biliary tract cancer (BTC). M Zuo, A Rashid, C Churi, MC Hung, M Javle Molecular Cancer Therapeutics 12 (11_Supplement), C171-C171, 2013 | | 2013 |
Abstract B132: Next generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA). CR Churi, A Rashid, R Shroff, L Mishra, M Zuo, A Kaseb, F Janku, ... Molecular Cancer Therapeutics 12 (11_Supplement), B132-B132, 2013 | | 2013 |